GTX INC | Intellectual Property | Business Contracts

First Amendment to the Amended and Restated License Agreement Between the University of Tennessee Research Foundation and the Registrant dated August 22, 2022 (Filed With SEC on November 3, 2022)

Amended and Restated License Agreement between the University of Tennessee Research Foundation and the Registrant Oncternal Therapeutics, Inc. dated March 9, 2022 (Filed With SEC on March 10, 2022)

Amendment #3 to Amended and Restated License Agreement between Oncternal Therapeutics, Inc. and the Regents of the University of California, dated February 5, 2021 (Filed With SEC on March 11, 2021)

Amendment #2 to Amended and Restated License Agreement between Oncternal Therapeutics, Inc. and the Regents of the University of California, dated May 15, 2019 (Filed With SEC on March 16, 2020)

Amendment No. 1 to Commercial License Agreement between Selexis SA and Oncternal Therapeutics, Inc., dated February 7, 2020 (Filed With SEC on March 16, 2020)

Exclusive License Agreement between Georgetown University and Oncternal Therapeutics, Inc., dated March 26, 2014 (Filed With SEC on April 8, 2019)

Commercial License Agreement between Selexis SA (predecessor to Oncternal Therapeutics, Inc.) and ROAR Therapeutics, LLC, dated May 19, 2014 (Filed With SEC on April 8, 2019)

Amendment to Exclusive License Agreement between Georgetown University and Oncternal Therapeutics, Inc., dated March 17, 2016 (Filed With SEC on April 8, 2019)

License Agreement between Oncternal Therapeutics, Inc. and Velos Biopharma Holdings, LLC, dated February 6, 2018 (Filed With SEC on April 8, 2019)

Amended and Restated License Agreement between Oncternal Therapeutics, Inc. and The Regents of the University of California, dated August 31, 2018 (Filed With SEC on April 8, 2019)

Amendment #1 to Amended and Restated License Agreement between Oncternal Therapeutics, Inc. and the Regents of the University of California, dated March 25, 2019 (Filed With SEC on April 8, 2019)

License Agreement, effective March 1, 2015, between the Registrant and University of Tennessee Research Foundation (Filed With SEC on March 18, 2019)

Amendment #1 to the License Agreement, dated November 12, 2015, between the Registrant and University of Tennessee Research Foundation (Filed With SEC on March 18, 2019)

Amendment #2 to the License Agreement, as amended, dated August 12, 2016, between the Registrant and University of Tennessee Research Foundation (Filed With SEC on March 18, 2019)

Amendment #3 to the License Agreement, as amended, dated April 6, 2017, between the Registrant and University of Tennessee Research Foundation (Filed With SEC on March 18, 2019)

Amendment #4 to the License Agreement, as amended, dated October 23, 2018, between the Registrant and University of Tennessee Research Foundation (Filed With SEC on March 18, 2019)

GTX INC (85) | Intellectual Property (16)